India has dispatched approximately three tonnes of anti-tuberculosis medicines to Colombo, flown in aboard an Indian Air Force C-130J transport aircraft.
The consignment was announced by Indian External Affairs Minister S. Jaishankar, who said India remained committed to supporting Sri Lanka’s public health system, Newswire reported.
A supply chain under strain
Anti-tuberculosis treatment is a category where continuity matters more than volume. TB regimens run for a minimum of six months and depend on uninterrupted daily dosing; an interruption in supply does not merely delay treatment but raises the risk of drug resistance developing in patients midway through a course.
Sri Lanka’s state health system procures most of its essential medicines centrally and has faced repeated pressure on pharmaceutical stocks since the 2022 economic crisis, with donations and concessional credit lines used to bridge gaps in specific categories.
Part of a wider health pipeline
The delivery sits alongside a run of Indian-supported health infrastructure in Sri Lanka. Indian grants are among the funding sources — with JICA loans — for the Rs. 7.1 billion of hospital projects across four districts for which the President was to lay foundation stones in September, a programme that includes an emergency complex at Mannar.
Health has been one of the steadier strands of the bilateral relationship, running through medicine consignments, hospital construction grants and equipment transfers rather than through single large agreements.
Neither the Sri Lankan Health Ministry’s own statement on the consignment nor a breakdown of which anti-TB formulations it contains had been published at the time of writing, and no verified Sri Lankan newsroom other than the outlet cited had filed on the delivery.
